Teza Capital Management LLC Moderna, Inc. Transaction History

Teza Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $467,912 - $632,726	5,481 New	5,481 $584,000
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $310,440 - $407,684	3,220 New	3,220 $332,000
Q1 2023 Feb 22, 2024	BUY	$135.66 - $197.02 $391,786 - $568,993	2,888 New	2,888 $443,000
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $663,106 - $963,033	4,888 New	4,888 $750,000
Q3 2021 Nov 10, 2021	SELL	$221.9 - $484.47 $418,725 - $914,194	-1,887 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$129.91 - $234.98 $1.2 Million - $2.16 Million	-9,211 Reduced 83.0%	1,887 $443,000
Q1 2021 May 13, 2021	BUY	$109.18 - $185.98 $1.21 Million - $2.06 Million	11,098 New	11,098 $1.45 Million
Q1 2020 May 11, 2020	SELL	$17.78 - $31.58 $395,409 - $702,307	-22,239 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$13.93 - $21.28 $159,414 - $243,528	11,444 Added 106.01%	22,239 $435,000
Q3 2019 Nov 12, 2019	BUY	$12.26 - $18.07 $132,346 - $195,065	10,795 New	10,795 $172,000

1,112

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $23.6B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.